Table 2.

Annual incremental cost from the perspective of the National Malaria Control Program ($US)

Policy options	mRDT costs	Drug costs	Total cost	Incremental cost
AL + quinine	6,350,032	14,523,023	20,873,055	Reference
AL + DhP	6,325,074	14,483,558	20,808,632	−64,423 (0.3 %)
DhP + AL	6,232,222	15,356,589	21,588,811	780,180 (3.8 %)

AL artemether–lumefantrine, DhP dihydroartemisinin–piperaquine, mRDT Rapid Diagnostic Test for malaria